# SODIUM ACETATE
> **ANDA220274** · Abbreviated New Drug Application (Generic) · Sponsor: EXTROVIS · Approved 2026-04-17
## Drug
- **FDA Application Number:** ANDA220274
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SODIUM ACETATE
- **Generic name:** Sodium Acetate
- **Active ingredients:** SODIUM ACETATE
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** EXTROVIS
- **First approval:** 2026-04-17
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220274)
---
*MORVS · CC0 1.0*